Protection of PC12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity

Free Radical Biology and Medicine

Volumn 25, Issue 4-5, 1998, Pages 512-518

  Kim Han, Jeong Sook ^a   Sun, Albert Y ^a  

^a University of Missouri   (United States)

Author keywords

Apoptosis; Free radical; Glutathione peroxidase; L DOPA; Oxidative mechanisms; PC12 cells

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; LEVODOPA; MESSENGER RNA; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSFECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CYTOPROTECTION; GENE EXPRESSION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LEVODOPA; NEURONS; PC12 CELLS; RATS; TERT-BUTYLHYDROPEROXIDE; TRANSFECTION;

ANIMALIA;

EID: 0032171625     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00076-8     Document Type: Article

References (43)

1. Olanow C.W. Dopa and dopamine cause cultured neuronal death in the presence of iron. Neurology. 40:(Suppl. 3):1990;32-37.
2. Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:(Suppl. 3):1996;S161-S170.
3. Yang W.L., Sun A.Y. Paraquat-induced free radical reaction in mouse brain microsomes. Neurochem. Res. 23:1998;47-53.
4. Hornykiewicz O. The mechanisms of action of L-dopa in Parkinson's disease. Life Sci. 15:1994;1249-1259.
5. Rinne U.K. Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurol. Scand. 95:(Suppl.):1983;19-26.
6. Chase T.N., Fabbrini C., Juncos J.L., Mouradian M.M. Motor response complications with chronic levodopa therapy. Adv. Neurol. 53:1990;377-381.
7. Ogawa N. Levodopa and dopamine agonists in the treatment of Parkinson's disease advantages and disadvantages . Eur. J. Neurol. 34:(Suppl. 3):1994;20-28.
8. Birkmayer W., Knoll J., Riederer P., Youdim M.B.H., Hars V., Marton J. Increased life expectancy resulting from addition of L-deprenyl to L-dopa treatment in Parkinson's disease a longterm study . J. Neural Transm. 64:1985;113-127.
9. Gerlack M., Youdim M.B.H., Riederer P. Pharmacology of selegiline. Neurology. 47:(Suppl. 3):1996;S137-S145.
10. Blunt S.B., Jenner P., Marsden C.D. Suppressive effect of L-DOPA on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Movement Disorders. 8:1993;129-137.
11. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. L-dopa cytotoxicity to PC12 cells in culture is via autoxidation. J. Neurochem. 64:1995;825-832.
12. Alexander T., Sortwell C.E., Sladek C.D., Roth R.H., Steece-Collier K. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplant. 6:1997;309-315.
13. Mena M.A., Pardo B., Paino C.L., DeYebenes G. Levodopa toxicity in foetal rat midbrain neurones in culture modulation by ascorbic acid . Neuroreport. 4:1993;438-440.
14. Mytillnineou C., Han S.K., Cohen G. Toxic and protective effects of L-dopa on mesencephalic cell cultures. J. Neurochem. 61:1993;1470-1478.
15. Tanaka M., Sotomatsu A., Kanai H., Hirai S. DOPA and dopamine cause cultured neuronal death in the presence of iron. J. Neurol. Sci. 101:1991;198-203.
16. Ho Y.S., Howard A.J., Crapo J.D. Cloning and characterization of the rat glutathione peroxidase gene. Nucleic Acids Res. 16:1988;5207.
17. Ho Y.S., Howard A.J. Nucleotide sequence of a rat glutathione peroxidase cDNA. Nature. 301:1992;5-9.
18. Michiels C., Raes M., Topussaint O., Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17:1994;235-248.
19. Trepanier G., Furling D., Purmira J., Mirault M.E. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience. 75:1996;231-243.
20. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
21. 2+-induced cytotoxicity in PC12 cells. J. Neurochem. 63:1994;895-902.
22. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. NeuroReport. 8:1997;1499-1502.
23. Draczynska-Lusiak, B.; Doung, A.; Sun, A. Y. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer's disease. Chem. Mol. Neuropathol. in press; 1998.
24. Draczynska-Lusiak B., Chen Y.M., Sun A.Y. Oxidized lipoproteins activate NF-κB binding activity and apoptosis in PC12 cells. NeuroReport. 9:1998;527-532.
25. Muller S.R., Sullivan P.D., Clegg D.O., Feinstein S.C. Efficient transfection and expression of heterologous genes in PC12 cells. DNA Cell Biol. 9:1990;221-230.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
27. Gunzler W.A., Flohe L. Glutathione peroxidase. Greenwald R.A. CRC handbook of methods for oxygen radical research. 1985;285-290 CRC Press, Boca Raton, FL.
28. Spina M.B., Cohen G. Exposure of school synaptosomes to L-DOPA increases levels of oxidized glutathione. J. Pharmacol. Exp. Ther. 247:1988;502-507.
29. Spencer J.P.E., Jenner A., Halliwell B. Superoxide dependent depletion of reduced glutathione by L-DOPA and dopamine relevance to Parkinson's disease . Neuroreport. 6:1995;1480-1484.
30. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
31. Jackson G.R., Apffel L., Werrbach-Perez K., Perez-Polo J.R. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury I. Stimulation of hydrogen peroxide resistance . J. Neurosci. Res. 25:1990;360-368.
32. Nistico G., Ciriolo M.R., Fiskin K., Iannone M., DeMartino A., Rolilio G. NGF restores decrease in catalase and increases in glutathione peroxidase activity in the brain of aged rats. Neurosci. Lett. 130:1991;117-119.
33. Greene L.A., Aletta J.M., Rukenstein A., Green S.H. PC12 pheochromocytoma cells culture, nerve growth factor treatment and experimental exploitation . Methods Enzymol. 147:1987;207-216.
34. Haviv R., Lindenboim L., Li H., Yuan J., Stein R. Need for caspuses in apoptosis of trophic factor-deprived PC12 cells. J. Neurosci. Res. 50:1997;69-80.
35. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation implication for Parkinson's disease . Proc. Natl. Acad. Sci. USA. 86:1989;1398-1400.
36. Lai C-T, Yu P.H. Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SYSY cells. Biochem. Pharmacol. 53:1997;367-372.
37. Miura T., Marioka S., Ogiso T. Lipid peroxidation inhibited by monoamines. Res. Commun. Mol. Pathol. Pharmacol. 93:1996;57-67.
38. Spencer J.P.E., Jenner A., Aruoma O.I., Evans P.J., Kaur H., Dexter D.T., Jenner P., Lees A.J., Massden D.C., Halliwell B. Intense oxidative DNA damage promoted by L-DOPA and its metabolites Implication for neurodegenerative disease . FEBS Lett. 353:1994;246-250.
39. Hom D.G., Jiang O., Hong E.J., Mo J.Q., Andersen J.K. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Mol. Brain Res. 46:1997;154-160.
40. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
41. Adams J.D. Jr, Klaidman L.K., Leung A.C. Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 15:1993;181-186.
42. Chacon, J. N.; Chedekel, M. R.; Land, E. J.; Truscott, T. G. Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion. Biochem. Biophys. Res. Commun.144:957-964; 1987. 43.
43. Fahn S. Is levodopa toxic? Neurology. 47:(Suppl. 3):1996;S184-S195.